Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Diabetic control and microvascular complications: The near-normoglycaemic experience


  1. 1.

    Tchobroutsky G (1978) Relation of diabetic control to development of microvascular complications. Diabetologia 15:143–152

  2. 2.

    Doft BH, Kingsley LA, Orchard TF, Kuller L, Drash A, Becker D (1984) The association between long-term diabetic control and early retinopathy. Ophthalmology 91: 763–769

  3. 3.

    Weber B, Burger W, Hartmann R, Hövener G, Malchus R, Oberdisse U (1986) Risk factors for the development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29: 23–29

  4. 4.

    Klein R, Klein BEK, Moss SE, Cavid MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age of diagnosis is less than 30 years. Arch Ophthalmol 102: 520–526

  5. 5.

    Sjølie AK (1985) Ocular complications in insulin treated diabetes mellitus. Acta Ophthalmol 63 (Suppl 172)

  6. 6.

    Rand LI, Krolewski AS, Aiello LM, Warran JH, Baker RS, Maki T (1985) Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 313: 1433–1438

  7. 7.

    Pirart F (1977) Diabete et complications degeneratives. Presentation d'une etude prospective portant sur 4400 cas observe entre 1947 et 1973. Diabete Metab 3: 97–107, 173–182, 245–256

  8. 8.

    Parving H-H, Oxenbøll B, Svendsen PA, Christiansen JS, Andersen AR (1982) Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol 100: 550–555

  9. 9.

    Viberti GC, Hill RD, Jarrett RF, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430–1432

  10. 10.

    Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T (1984) Incipient nephropathy in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 406–410

  11. 11.

    Wiseman M, Viberti GC, Mackintosh D, Jarrett RF, Keen H (1984) Glycemia, arterial pressure and microalbuminuria in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 401–405

  12. 12.

    Deckert T, Poulsen JE (1981) Diabetic nephropathy: fault or destiny. Diabetologia 21: 178–183

  13. 13.

    Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia 25: 496–501

  14. 14.

    Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596

  15. 15.

    Hasslacher C, Stech W, Wahl P, Ritz E (1985) Blood pressure and metabolic control as risk factors for nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 28: 6–11

  16. 16.

    Keen H (1984) Normoglycaemic re-entry and diabetic complications. Diabetic Med 1: 85–87

  17. 17.

    Irsigler K, Knitz H, Najemnik C, Freiger H (1979) Reversal of florid diabetic retinopathy. Lancet 2:1068

  18. 18.

    White MC, Kohner EM, Pickup FC, Keen H (1981) Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: a case report. Br J Ophthalmol 65: 307–314

  19. 19.

    Puklin JE, Tamborlane WV, Felig P, Genel M, Sherwin RS (1982) Influence of long-term insulin infusion pump treatment of type I diabetes on diabetic retinopathy. Ophthalmology 89: 735–747

  20. 20.

    Lawson PM, Champion MC, Canny CLB, Kingsley R, White MC, Dupre J, Kohner EM (1982) Continuous subcutaneous insulin infusion does not prevent progression of proliferative and preproliferative retinopathy. Br J Ophthalmol 66: 762–766

  21. 21.

    Dahl-Jørgensen K, Hanssen KF, Brinchmann-Hansen O (1983) What happens to the retina as diabetic control is tightened? Lancet 1: 652

  22. 22.

    van Ballegooie E, Hooymans JMM, Timmerman Z, Reitsma WD, Sluiter WJ, Schweitzer NMJ, Doorenbos H (1984) Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care 7: 236–242

  23. 23.

    Friberg TR, Rosenstock F, Sanborn G, Vagheti A, Raskin P (1985) The effect of long-term near normal glycemic control on mild diabetic retinopathy. Ophthalmology 92:1051–1058

  24. 24.

    Barbosa J (1983) Diabetes: The science and the art, hyperglycemia complications. Arch Intern Med 143:1118–1119

  25. 25.

    Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, The Steno Study Group (1983) Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetes. Lancet 1: 200–204

  26. 26.

    Lauritzen T, Frost-Larsen K, Larsen H-W, Deckert T, and the Steno Study Group (1985) Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 35 (Suppl 3): 74–79

  27. 27.

    Lauritzen T (1985) Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy. Dan Med Bull 32,2:104–118

  28. 28.

    Kroc Collaborative Study Group (1985) Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 311: 365–372

  29. 29.

    Testa MA, Puklin JE, Sherwin RS, Simonson DC (1985) Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSII or conventional insulin treatment. Diabetes 34 (Suppl 3): 61–68

  30. 30.

    Kroc Study Group (1985) Effect of diabetic control on retinopathy. Follow-up report of the Kroc randomized clinical trial. Invest Ophthalmol Vis Sci 26 (Suppl 1): 85

  31. 31.

    Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes Ø, Aker Diabetes Group (1985) Rapid tightening of blood glucose control leads to transient deterioration in retinopathy in insulin-dependent diabetes mellitus — The Oslo Study. Br Med J 290: 811–815

  32. 32.

    Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Bjoro T, Sandvik L, Aagenæs Ø, Aker Diabetes Group (1986) Near-normoglycemia retards the progression of early diabetic retinopathy and neuropathy. Br Med J (in press)

  33. 33.

    Beck-Nielsen H, Richelsen B, Mogensen CE, Olsen T, Ehlers N, Nielsen CB, Charles P (1985) Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM. Diabetes Care 8: 585–589

  34. 34.

    Feldt-Rasmussen B, Mathiesen ER, Hegedus L, Deckert T (1986) Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med 314: 665–670

  35. 35.

    Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect on the progression of diabetic renal disease during 2 years of strict metabolic control in insulin-dependent diabetes. Diabetes 35: 425 A

  36. 36.

    Baudoin C, Maneschi F, Quentil G, Soubrane G, Hayes T, Jones G, Cascas G, Kohner EM (1983) Quantitative evaluation of fluorescein angiograms: Microaneurism counts. Diabetes 32 (Suppl 2): 8–13

  37. 37.

    Harrad RA, Plump AP, Rose GE, Morris RW, Sönksen PH (1984) Two year prospective study of improved control in diabetic patients with background retinopathy. Diabetologia 27: 285 A

  38. 38.

    Daneman D, Drash AL, Lobes LA, Becker DF, Baker LM, Travis LB (1981) Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome). Diabetes Care 4: 360–365

  39. 39.

    Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L, and Oslo Diabetes Study Group (1985) Effects of intensified insulin treatment on various lesions of diabetic retinopathy. Am J Ophthalmol 100: 644–653

  40. 40.

    Brinchmann-Hansen O, Dahl-Jørgensen K, Hanssen KF, Sandvik L. Diameter of retinal vessels and progression of diabetic retinopathy. Unpublished observation

  41. 41.

    Tamborlane WV, Puklin FE, Bergman M, Verdonk C, Rudolf MC, Felig P, Genel M, Sherwin R (1982) Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care 5 [Suppl 1]: 58–64

  42. 42.

    Koivisto VA, Huttunen N-P, Vierikko P (1981) Continuous subcutaneous insulin infusion corrects exercise-induced albuminuria in juvenile diabetes. Br Med J 282: 778–779

  43. 43.

    Feldt-Rasmussen B, Baker L, Deckert T (1985) Exercise as a provocative test in early renal disease in Type 1 (insulin-dependent) diabetes: Albuminuric, systemic and renal hemodynamic responses. Diabetologia 28: 389–396

  44. 44.

    Parving H-H, Noer I, Deckert T, Errin P-E, Nielsen SL, Lyngsøe J, Mogensen CE, Rorth M, Svendsen PA, Trap-Jensen J, Lassen NA (1976) The effect of metabolic regulation on microvasular permability to small and larbe molecules in short term juvenile diabetics. Diabetologia 12: 161–166

  45. 45.

    Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H (1983) Long-term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. Br Med J 286: 598–601

  46. 46.

    Viberti GC, Pickup FC, Jarrett RF, Keen H (1979) Effect of control of blood glucose on urinary excretion of albumin and B2-micro-globulin in insulin-dependent diabetes. N Engl J Med 300: 638–641

  47. 47.

    Gavarella A, Vannini P, Flammini M, Bacci L, Forlani G, Borgnino (1985) Effect of long-term near-normoglycemia on the progression of nephropathy. Diabete Metab 77: 3–8

  48. 48.

    Bending JJ, Viberti GC, Watkins PJ, Keen H (1986) Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control. Br Med J 292: 83–86

  49. 49.

    Deckert T, Lauritzen T, Parving H-H, Christiansen JS, The Steno Study Group (1984) Effect of two years of strict metabolic control on kidney function in long-term insulin-dependent diabetes. Diab Nephrop 3: 6–10

  50. 50.

    Feldt-Rasmussen B, Mathiesen ER (1984) Variability of urinary albumin excretion in incipient diabetic nephropathy. Diab Nephrop 3: 101–103

  51. 51.

    Feldt-Rasmussen B, Mogensen CE, Christiansen CK, Mathiesen ER, Deckert T (1984) Blood glucose control and diabetic microangiopathy. N Engl J Med 311: 1577–1528

  52. 52.

    Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ (1985) Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 708: 861–880

  53. 53.

    Sima AAF, Brismar T (1985) Reversible diabetic nerve dysfunction: Structural correlates to electrophysiological abnormalities. Ann Neurol 18: 21–29

  54. 54.

    Sima AAF, Lattimer SA, Yagihashi S, Greene DA (1986) Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest 77: 474–484

  55. 55.

    Gregersen G (1967) Diabetic neuropathy: Influence of age, sex, metabolic control and duration of diabetes on motor nerve conduction velocity. Neurology (NY) 17: 972–980

  56. 56.

    Ward JD, Barnes CG, Fisher DJ, Jessup JD, Baker RWR (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetes. Lancet 1: 428–430

  57. 57.

    Graf RJ, Halter JB, Pfeifer MA, Harlan E, Brozovich BSE, Porte D (1981) Glycemic control and nerve conduction abnormalities in noninsulin dependent diabetic subjects. Ann Intern Med 94: 307–311

  58. 58.

    Boulton AJM, Worth RC, Drury J, Hardisty CA, Wolf E, Cudworth AG, Ward JD (1984) Genetic and metabolic studies in diabetic neuropathy. Diabetologia 26:15–19

  59. 59.

    Boulton AJM, Drury J, Clark B, Ward JD (1982) Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 5: 386–390

  60. 60.

    Pietri A, Ehle AL, Raskin P (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–671

  61. 61.

    Gambardelia S, Napoli A, Spallone V, Verrastsro AM, Lazzan R, Geraldine C, Sideri G, Manzinger G (1983) Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetes. J Endocrinol Invest 6: 363–369

  62. 62.

    Service FJ, Rizz RA, Daube JR, O'Brien PC, Dyck PJ (1985) Near normoglycemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727

  63. 63.

    Jaspan J, Maselli R, Herold K, Bartkus C (1983) Treatment of severe painful neuropathy with an aldose reductase inhibitor: Relief of pain and improved somatic and autonomic nerve function. Lancet 2:758–762

  64. 64.

    Barbosa J (1984) Do genetic factors play a role in the pathogenesis of diabetic microangiopathy. Diabetologia 27: 487–492

  65. 65.

    Assal JP, Berger M, Gay N, Canivet J (eds) (1983) Diabetes education: how to improve patient education, ICS No 624. Excerpta Medica, Amsterdam

  66. 66.

    Tattersall RB, McCulloch DK, Aveline M (1985) Group therapy in the treatment of diabetes. Diabetes Care 8: 180–188

  67. 67.

    Unger RH (1982) Meticulous control of diabetes: Benefits, risks and precautions. Diabetes 31: 479–483

  68. 68.

    Thorsteinsson B, Pramming S, Lauritzen T, Binder C (1986) Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients: relation to daily median blood glucose concentrations. Diabetic Med 3: 147–151

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hanssen, K.F., Dahl-Jørgensen, K., Lauritzen, T. et al. Diabetic control and microvascular complications: The near-normoglycaemic experience. Diabetologia 29, 677–684 (1986).

Download citation


  • Public Health
  • Internal Medicine
  • Human Physiology
  • Metabolic Disease
  • Diabetic Control